UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030266
Receipt number R000034566
Scientific Title Impact of extracellular water-to-total body water ratio using bioelectrical impedance analysis in patients with heart failure
Date of disclosure of the study information 2017/12/05
Last modified on 2017/12/05 12:58:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of extracellular water-to-total body water ratio using bioelectrical impedance analysis in patients with heart failure

Acronym

Extracellular water-to-total body water ratio in patients with heart failure

Scientific Title

Impact of extracellular water-to-total body water ratio using bioelectrical impedance analysis in patients with heart failure

Scientific Title:Acronym

Extracellular water-to-total body water ratio in patients with heart failure

Region

Japan


Condition

Condition

Heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the usefulness of the measurement of body composition and edema status based on extracellular water (ECW)-to-total body water (TBW) ratio using bioelectrical impedance analysis (BIA) for estimating heart failure status, efficacy of treatment and predicting outcome in patients with heart failure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Correlation between rate of change in ECW/TBW ratio and conventional parameters (body weight, echographic parameters and BNP or NT-proBNP values) at acute and chronic phase

Key secondary outcomes

Relationship of stable-phase ECW/TBW ratio or rate of change in ECW/TBW ratio and all cause death and major adverse outcomes (cardiovascular death and heart failure-related re-admission)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Measurement of extracellular water (ECW)-to-total body water (TBW) ratio using bioelectrical impedance analysis (BIA) and conventional parameters (body weight, echographic parameters and BNP or NT-proBNP values) at acute and chronic phase in hospitalized patients with heart failure

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients required hospitalization due to heart failure

Key exclusion criteria

1. Patients with pacemaker, implantable cardioverter defibrillator or cardiac resynchronization therapy devise
2. Inadequate patients by physician's discresion

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kei Yunoki

Organization

Tsuyama Chuo Hospital

Division name

Department of Cardiology

Zip code


Address

1756, Kawasaki, Tsuyama-City, Okayama, Japan

TEL

0868-21-8111

Email

kei.yunoki@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Yusuke Nanba

Organization

Tsuyama Chuo Hospital

Division name

Department of Cardiology

Zip code


Address

1756, Kawasaki, Tsuyama-City, Okayama, Japan

TEL

0868-21-8111

Homepage URL

http://www.tch.or.jp/clinical_research.html

Email

d5w8y.nmb@gmail.com


Sponsor or person

Institute

Department of Cardiology, Tsuyama Chuo Hospital

Institute

Department

Personal name



Funding Source

Organization

Tsuyama Chuo Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

津山中央病院(岡山県)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 05 Day

Last modified on

2017 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034566


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name